The Davos of Precision Medicine. Driving the future of patient care.
Next-Gen Therapeutics
Cell therapy, targeted oncology, and programmable medicines, with the hard questions left in.
See the full Track 1 agenda Swipe to see all three daysEngineered Cell & Gene Therapy Platforms
Off-the-shelf cells, AI-enabled design, in vivo delivery, manufacturing, and the solid-tumor challenge.
Katy Rezvani, MD Anderson
Frederick Locke, Moffitt
Immunotherapies & Targeted Therapies
Checkpoint failure, decision-grade biomarkers, resistance biology, adaptive combinations, and rare cancers.
Antoni Ribas, UCLA
Gerold Meinhardt, Daiichi Sankyo
Programmable Genetic Medicines
CRISPR, base and prime editing, programmable RNA, protein fate, and the delivery layer that decides what reaches patients.
AI and Computational Medicine
Clinical AI, AI in diagnostics, and AI in drug discovery, with real builders and health-system leaders on stage.
See the full Track 2 agenda Swipe to see all three daysMultimodal AI in Diagnostics
Computational pathology, omics foundation models, companion diagnostics, and what is ready for clinical use.
Fei-Fei Li, Stanford
Andrew Ng, DeepLearning.AI
Clinical AI: Deployment, Decision Support & RWE
AI agents, foundation models, safety, trials, and the realities of putting clinical AI into production.
Ziad Obermeyer, Dandelion Health
John Halamka, Mayo Clinic
AI in Drug Discovery & Computational Biology
Causal targets, proprietary data, designed proteins, smarter trials, and what survives contact with drug development.
David Baker 🥇, U. Washington
Daphne Koller, insitro
Precision Diagnostics
Blood-based and multimodal diagnostics from screening and interception to MRD, therapy guidance, and organ health.
See the full Track 3 agenda Swipe to see all three daysFrom Screening to Interception
Risk-stratified screening, early detection, pre-cancer, multimodal signals, and the path from detection to action.
Mary-Claire King, U. Washington
Rebecca Fitzgerald, Cambridge
Liquid Biopsy: Therapy Guidance & Monitoring
MRD, response, resistance, therapy selection, multimodal monitoring, and evidence strong enough to change care.
Maximilian Diehn, Stanford
Sarah-Jane Dawson, U. Melbourne
Blood-Based Diagnostics Beyond Cancer
Transplant and organ health, infection, maternal-fetal health, and what it takes to reach standard of care.
Joseph DeRisi, UCSF
Alexandre Loupy, APHP / Inserm
Integrated Precision Medicine
Genomic diagnosis, population screening, implementation, prevention, and healthspan from discovery to operating model.
See the full Track 4 agenda Swipe to see all three daysFrom Genomic Diagnosis to the Human Phenome
Rare-disease diagnosis, population screening, long reads, phenomics, and the next layer beyond the exome.
Wendy Chung, Harvard
Eric Lander, Broad
Integration & Implementation
Operating models, coverage, decision support, evidence, and the health-system work required to scale precision medicine.
Victor Dzau, NAM
Hal Paz, Khosla Ventures
Precision Aging, Prevention & Healthspan
Aging biology, GLP-1 and metabolism, biomarkers, wearables, prevention, and credible clinical translation.
Daniel Drucker, Sinai Health
Andrea Maier, NUS
Spatial & Translational Disease Biology
See the full Track 5 agenda Swipe to see all three daysSpatial Biology & Tissue Architecture
Cell atlases, tissue architecture, spatial proteomics, AI, pathology, and reproducible clinical translation.
Sarah Teichmann, Cambridge
Aviv Regev, Genentech
Precision Immunology
Immune reset, tolerance, biomarkers, macrophage biology, inflammation, and better clinical-development strategies.
Miriam Merad, Mount Sinai
Jeffrey Bluestone, UCSF
Precision Neurology & Brain Health
Blood tests, imaging, neurodegeneration, brain rhythms, and the infrastructure needed to make precision neurology scale.
Thomas Südhof 🥇, Stanford
Li-Huei Tsai, MIT
